◆ SpookStack

FD-302a (Rev. 10-6-95) 279A-WF-222936-DUGWAY ,On 12/07/2006 _,Page . b6 Continuation of FD-302 of b7C on 09/23/1997, but did not ship this to UsAMRIID based on the fact that had already shipped more than enough product to fulfill the original contract. theorized that a batch or spores stored in water aue .'naoon, duonng pue and daos uen aann go ponend nuon e oop unable to be cleaned. However, the fact the 7th lot was. immediately purified by Ivins without unnecessary storage and the fact that spores produced for this project were still utilizable after several years made this "pnA seepage" scenario unlikely in opinion. Based on detailed listings of the 2oo4 consent search collected items identified the sEm stubs as well as the "EM specimens," bearing the same dates as 1997 production runs, as QA/Qc derived samples and sEM stubs from the 1997 production runs. affirmed that there were mistakes in additive (salts) concentrations in the August of 1997 s0p, aenerated upon completion of the 1997 spore production project. confirmed that the concentration for Feso, was higher than the concentration called for in the original Leighton-Doi protocol. also confirmed that this mistake may have carried over into the latter 1997 production runs. believes that shipping records for AEs samples at Dugway's Life Sciences Division are accurate in that there did not recall any 2004 envelope aerosolization study at Dugway, and therefore could not provide a client or Principle investigator for this project. describes contractor clearances to work in the suite at Dugway as needing a secret clearance, having completed the personal reliablility program (PRp), having completed a mentoring program, and having the propep vaccinations. Contractors were escorted within the suite.